2005
DOI: 10.1021/jm050635e
|View full text |Cite
|
Sign up to set email alerts
|

Radioiodinated Flavones for in Vivo Imaging of β-Amyloid Plaques in the Brain

Abstract: In vivo imaging of beta-amyloid (A beta) peptide aggregates in the brain may lead to early detection of Alzheimer's disease (AD) and monitoring of the progression and effectiveness of AD treatment. The purpose of this study was to develop novel amyloid imaging agents based on flavone as a core structure. Radioiodinated flavone derivatives were designed and synthesized. The binding affinities of flavone derivatives for A beta aggregates varied from 13 to 77 nM. When in vitro plaque labeling was carried out usin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

5
58
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 73 publications
(64 citation statements)
references
References 28 publications
5
58
0
Order By: Relevance
“…Recently, we have reported that flavonoids including chalcone, flavone, and aurone serve as useful molecular scaffolds in the development of imaging agents for β-amyloid plaques in the brain [23][24][25][26][27][28] . Initially, we designed and synthesized four 99m Tc-labeled In the present study, to develop more useful 99m Tc imaging agents for the clinical diagnosis of AD, we synthesized two flavone and aurone derivatives with BAT as a chelation ligand.…”
Section: Ono Et Al 3/38mentioning
confidence: 99%
See 2 more Smart Citations
“…Recently, we have reported that flavonoids including chalcone, flavone, and aurone serve as useful molecular scaffolds in the development of imaging agents for β-amyloid plaques in the brain [23][24][25][26][27][28] . Initially, we designed and synthesized four 99m Tc-labeled In the present study, to develop more useful 99m Tc imaging agents for the clinical diagnosis of AD, we synthesized two flavone and aurone derivatives with BAT as a chelation ligand.…”
Section: Ono Et Al 3/38mentioning
confidence: 99%
“…Based on this success, efforts were made to search for comparable 99m Tc imaging agents that target binding sites on -amyloid plaques in the brain of AD patients. Several 99m Tc-labeled imaging probes have been developed (Figure 1), but no clinical study of them has been reported [19][20][21][22] .Recently, we have reported that flavonoids including chalcone, flavone, and aurone serve as useful molecular scaffolds in the development of imaging agents for β-amyloid plaques in the brain [23][24][25][26][27][28] . Initially, we designed and synthesized four 99m Tc-labeled In the present study, to develop more useful 99m Tc imaging agents for the clinical diagnosis of AD, we synthesized two flavone and aurone derivatives with BAT as a chelation ligand.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…We have previously reported Aβ imaging agents based on flavonoid derivatives, such as flavones 15,16 , chalcones [17][18][19][20] , aurones 21,22 , and styrylchromones 23 studies demonstrated that chalcone derivatives fluoro-pegylated at the p-position of the 1-phenyl ring showed a sufficient brain uptake with a good binding capacity to Aβ plaques 19 . In addition, radioiodinated flavonoids, such as flavone and aurone derivatives, with a methoxy or oligoethyleneoxy group at the p-position of the 3-phenyl ring have the properties of high brain uptake and rapid clearance from the brain without significant decrease in the binding affinity for Aβ 15,22 .…”
Section: Introductionmentioning
confidence: 99%
“…Modifications of the benzamide moiety of the general structure 1 aimed at lowering the lipophilicity might allow for penetrating the brain while maintaining favorable Aβ-plaque binding characteristics. Recent studies with modified amyloid ligands [11][12][13] provide encouragement to further explore this route. …”
mentioning
confidence: 99%